EP Patent

EP4452925A1 — Nanomaterial comprising diamines

Assigned to Beam Therapeutics Inc · Expires 2024-10-30 · 2y expired

What this patent protects

The present disclosure describes compositions, preparations, nanoparticles (such as lipid nanoparticles), and/or nanomaterials and methods of their use.

USPTO Abstract

The present disclosure describes compositions, preparations, nanoparticles (such as lipid nanoparticles), and/or nanomaterials and methods of their use.

Drugs covered by this patent

Patent Metadata

Patent number
EP4452925A1
Jurisdiction
EP
Classification
—
Expires
2024-10-30
Drug substance claim
No
Drug product claim
No
Assignee
Beam Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.